158 related articles for article (PubMed ID: 29849822)
1. CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.
Raschioni C; Bottai G; Sagona A; Errico V; Testori A; Gatzemeier W; Corsi F; Tinterri C; Roncalli M; Santarpia L; Di Tommaso L
Dis Markers; 2018; 2018():5018671. PubMed ID: 29849822
[TBL] [Abstract][Full Text] [Related]
2. Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases.
Strien L; Joensuu K; Heikkilä P; Leidenius MH
Anticancer Res; 2017 Jan; 37(1):175-182. PubMed ID: 28011488
[TBL] [Abstract][Full Text] [Related]
3. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
[TBL] [Abstract][Full Text] [Related]
4. [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].
Liu FF; Wei J; Lang RG; Fan Y; Cui LF; Gu F; Fu L
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):529-35. PubMed ID: 19094464
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
[TBL] [Abstract][Full Text] [Related]
7. Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
Tatara T; Mukohara T; Shimono Y; Yamasaki T; Imamura Y; Funakoshi Y; Toyoda M; Kiyota N; Takao S; Kono S; Kakeji Y; Minami H
J Surg Oncol; 2018 May; 117(6):1131-1136. PubMed ID: 29193094
[TBL] [Abstract][Full Text] [Related]
8. [Expression of chemokine CXCL12 and its receptor (CXCR4 and CXCR7) in different molecular subtypes of human breast carcinoma and the clinical significance].
Wu W; Qian L; Dai J; Ding B; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 42(2):147-153. PubMed ID: 28255115
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis.
Gadalla R; Hassan H; Ibrahim SA; Abdullah MS; Gaballah A; Greve B; El-Deeb S; El-Shinawi M; Mohamed MM
Breast Cancer Res Treat; 2019 Apr; 174(3):679-691. PubMed ID: 30632021
[TBL] [Abstract][Full Text] [Related]
10. Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients.
Dąbrowska E; Przylipiak A; Zajkowska M; Piskor BM; Sidorkiewicz I; Szmitkowski M; Lawicki S
Anticancer Res; 2020 Jun; 40(6):3221-3229. PubMed ID: 32487616
[TBL] [Abstract][Full Text] [Related]
11. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
12. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.
Aversa I; Zolea F; Ieranò C; Bulotta S; Trotta AM; Faniello MC; De Marco C; Malanga D; Biamonte F; Viglietto G; Cuda G; Scala S; Costanzo F
J Exp Clin Cancer Res; 2017 Aug; 36(1):104. PubMed ID: 28774348
[TBL] [Abstract][Full Text] [Related]
14. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
16. Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.
Hinton CV; Avraham S; Avraham HK
Clin Exp Metastasis; 2010 Feb; 27(2):97-105. PubMed ID: 18814042
[TBL] [Abstract][Full Text] [Related]
17. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast.
Liu F; Lang R; Wei J; Fan Y; Cui L; Gu F; Guo X; Pringle GA; Zhang X; Fu L
Histopathology; 2009 May; 54(6):741-50. PubMed ID: 19438749
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of CXCR4/CXCL12 overexpression to lymph node metastasis and chronic inflammation in cervical adenocarcinoma].
Wei M; Liang LZ; Zhang CQ; Xiong Y; Zhang Y; Shen Y; Li JQ
Ai Zheng; 2007 Mar; 26(3):298-302. PubMed ID: 17355795
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue.
Albert S; Hourseau M; Halimi C; Serova M; Descatoire V; Barry B; Couvelard A; Riveiro ME; Tijeras-Raballand A; de Gramont A; Raymond E; Faivre S
Oral Oncol; 2012 Dec; 48(12):1263-71. PubMed ID: 22776129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
